Mercy Hospital South — St Louis, Missouri

Mercy Hospital South is a clinical research site located in St Louis, Missouri, United States 63128.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Mercy Hospital South has participated in 233 clinical trials with 191 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Abbott Medical Devices.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Hospital South?

Mercy Hospital South has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Hospital South conducted?

Mercy Hospital South has 233 clinical trials on record, with 191 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia.

Is Mercy Hospital South accredited by Crixeo Health?

Mercy Hospital South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Hospital South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.